ReviewFatigue in cancer patients during and after treatment: prevalence, correlates and interventions
Introduction
Fatigue is a subjective experience that affects everybody. For healthy individuals, it might be a protective, sometimes even pleasant, regulatory response to physical or psychological stress. It seems to maintain a healthy balance between rest and activity. For people with specific diseases, fatigue often becomes a major distressing symptom and for people with cancer, fatigue has been described as a major concern during treatment, in the advanced stages of the disease and after curative treatment. Whereas healthy individuals report fatigue to be a pleasant, acute, normal, regulating phenomenon which helps them to schedule their daily rhythm and which disappears after a good night's sleep, cancer patients speak about chronic, unpleasant, distressing, life and activity-limiting fatigue throughout the day.
In various publications, different definitions to describe fatigue in patients with cancer have been used. From all these different descriptions, we conclude that fatigue is a subjective and multidimensional concept with several modes of expression: physical (e.g. diminished energy, need to rest), cognitive (e.g. diminished concentration or attention) and affective (e.g. decreased motivation or interest).
In this review, we focus on what is currently known about fatigue during and after treatment for cancer, based on empirical studies with reliable instruments. In the first part of our review (fatigue during treatment for cancer), studies are included in which fatigue was investigated in patients in the active phase of their disease. In the second part (fatigue after treatment for cancer), disease-free patients who completed cancer treatment are included. The prevalence of fatigue and correlates of fatigue are discussed. In addition, the literature concerning interventions to reduce fatigue in cancer patients is also examined. In Table 1, Table 2, Table 3, all of the reviewed studies are summarised. Study characteristics and key findings are described and, when possible, the effect size was calculated.
Section snippets
Method
We conducted a literature search in Medline, Current Contents (CC) and Psychlit for the period 1980–July 2001. In the first search, 154 different articles were found with the keywords FATIGUE and (CANCER or HODGKIN'S or TUMOR or TUMOUR or MALIGN* or HAEMATOLOG* or RADIOTHERAPY or RADIATION or CHEMOTHERAPY or HORMONE THERAPY) in the title. In a second search, we combined the words CANCER (or HODGKIN'S or TUMOR or TUMOUR or MALIGN* or HAEMATOLOG*) and (INTERVENTION or EXERCISE or PSYCHOTHERAPY or
Description of the reviewed studies
In Table 1, 26 publications are summarised in which fatigue was investigated in a sample of cancer patients during or immediately after treatment for cancer 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26. These 26 publications were based on 22 studies. As indicated in Table 1, some studies were based on the same sample of patients, answering different research questions. In 10 of these 22 studies, a homogenous group of cancer patients was
Description of the reviewed studies
In Table 2, 16 publications are summarised in which the focus was on ‘off-treatment fatigue’ 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42. These 16 publications were based on 13 studies. In these studies, fatigue complaints have been investigated in disease-free cancer patients, who completed curative treatment for cancer in the (recent) past. In seven of these 13 studies, a sample of breast cancer patients was investigated. In one study, Hodgkin's disease survivors, in one
Description of the reviewed studies
In Table 3, 12 controlled intervention studies are summarised. In five of these studies, fatigue was the main dependent variable 48, 50, 51, 52, 54. In the other seven studies, fatigue was one of the investigated outcome measures 43, 44, 45, 46, 47, 49, 53. All studies took place while patients were undergoing treatment for cancer or, in one study, just after treatment for cancer had finished (surgery, without adjuvant therapy). To the best of our knowledge, no intervention studies have been
Discussion
In the last 10 years, the amount of research on the relationship between cancer and fatigue has increased considerably. To give an indication, from the 181 articles we found using Medline, Current Contents and Psychlit, 20 were published between 1980 and 1990, and 161 were published between 1991 and 2001. From these 161 studies, 32 were published between 1991 and 1995 and 129 were published between 1996 and 2001. The conducted research has focused mainly on fatigue complaints during treatment
Acknowledgements
This research was funded by the Dutch Cancer Society.
References (56)
- et al.
Correlation between physical performance and fatigue in cancer patients
Ann. Oncol.
(1997) - et al.
Understanding the level of fatigue in cancer patients undergoing radiotherapy
J. Psychosom. Res.
(1998) - et al.
Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasisa pilot study
J. Pain Symptom. Manage.
(1999) - et al.
Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantationa longitudinal comparative study
J. Pain Symptom. Manage.
(1999) - et al.
Fatigue in women receiving adjuvant chemotherapy for breast cancercharacteristics, course, and correlates
J. Pain Symptom. Manage.
(1999) - et al.
Fatigue in patients with prostate cancer receiving hormone therapy
Eur. J. Cancer
(2000) - et al.
Fatigue in ambulatory patients with advanced lung cancer, prevalence, correlated factors, and screening
J. Pain Symptom. Manage.
(2001) - et al.
High level of fatigue in lymphoma patients treated with high dose therapy
J. Pain Symptom. Manage.
(2000) - et al.
Fatigue and psychiatric morbidity among Hodgkin's disease survivors
J. Pain Symptom. Manage.
(2000) - et al.
Preventive psychosocial intervention with newly diagnosed cancer patients
Gen. Hosp. Psychiatry
(1984)
Underreporting by cancer patientsthe case of response-shift
Soc. Sci. Med.
Correlates of fatigue in people with breast or lung cancer
Oncol. Nurs. Forum.
Attentional fatigue following breast cancer surgery
Res. Nurs. Health
Assessment of fatigue in cancer and non-cancer patients and in healthy individuals
Support Care Cancer
The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals
Cancer Nurs.
Fatigue-reducing strategies used by patients receiving treatment for cancer
Cancer Nurs.
Fatigue in patients with cancer receiving interferon alpha
Cancer Pract.
The experience of fatigue and other symptoms in patients receiving chemotherapy
Eur. J. Cancer Care Engl.
Fatigue in women with breast cancer receiving radiation therapy
Cancer Nurs.
Fatigue and radiotherapy(A) experience in patients undergoing treatment
Br. J. Cancer
Fatigue, depression and quality of life in cancer patientshow are they related?
Support Care Cancer
Fatigue in patients receiving chemotherapypatterns of change
Cancer Nurs.
Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy
Oncol. Nurs. Forum.
Fatigue, pain, and depression in pre-autotransplant breast cancer patients
Cancer Pract.
Fatigue in advanced cancera prospective controlled cross-sectional study
Br. J. Cancer
Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy
Radiat. Oncol. Investig.
The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue
Oncol. Nurs. Forum.
Cited by (407)
SARS-CoV-2 infection is associated with physical but not mental fatigue – Findings from a longitudinal controlled population-based study
2024, Journal of Psychosomatic ResearchBiomarkers of fatigue in oncology: A systematic review
2024, Critical Reviews in Oncology/HematologyThe GDF15-GFRAL axis mediates chemotherapy-induced fatigue in mice
2023, Brain, Behavior, and ImmunityQuality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy
2022, Clinical and Translational Radiation OncologyCitation Excerpt :Various patient- and disease-specific factors and RT modality may affect QoL. [4] Fatigue, a major component of QoL, is one of the most common side effects reported by cancer patients during and after treatment. [5–8] In many cases evaluation of QoL in patients having received RT remains challenging, since symptoms of cancer may deteriorate before improvement [9–10] and pre-treatment mental and physical status vary between patient populations. [11–13]